Lettmann Jason 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2024-03-14$11.31/sh+4,400$49,771→ 171,620 total
4 · ALX ONCOLOGY HOLDINGS INC · Filed Mar 18, 2024
Common Stock